All of the following drugs reduce afterload except
First, I need to recall that afterload is the resistance the heart must overcome to eject blood during systole. Drugs that reduce afterload lower this resistance, making it easier for the heart to pump. Common drugs that reduce afterload include ACE inhibitors, ARBs, hydralazine, nitrates, and calcium channel blockers like nifedipine. On the other hand, beta-blockers increase afterload because they reduce heart rate and contractility but can increase peripheral resistance.
So, if the correct answer is a beta-blocker, like metoprolol, that would be the exception. Let's structure the explanation. The core concept is about afterload-reducing drugs. The correct answer is a beta-blocker. The wrong options might include ACE inhibitors, nitrates, or calcium channel blockers. For each wrong option, explain why they reduce afterload. The clinical pearl could be that beta-blockers increase afterload, so they're used cautiously in certain conditions.
Wait, but I need to make sure the options are typical. Let's say the options are A. Nitroprusside, B. Enalapril, C. Metoprolol, D. Nifedipine. Then the correct answer is C. Metoprolol. So in the explanation, I need to detail that beta-blockers increase afterload, while the others decrease it. The clinical pearl would be to remember that beta-blockers are the exception here. Also, mention that metoprolol is a beta-1 blocker, which affects the heart, increasing afterload by increasing peripheral resistance. That's a key point for exams.
**Core Concept**
Afterload is the resistance the left ventricle must overcome to eject blood during systole. Drugs that reduce afterload (e.g., vasodilators) decrease systemic vascular resistance, improving cardiac efficiency in conditions like heart failure. Beta-blockers uniquely increase afterload by enhancing peripheral resistance and reducing compensatory mechanisms.
**Why the Correct Answer is Right**
Beta-blockers (e.g., metoprolol) increase afterload by blocking beta-1 receptors in the heart, reducing cardiac output and unmasking peripheral vasoconstriction. This contrasts with other afterload-reducing agents, which act via direct arterial dilation (e.g., ACE inhibitors, nitrates) or venous pooling (e.g., calcium channel blockers). Their mechanism is counterintuitive, as they are primarily used for rate control and myocardial oxygen demand reduction.
**Why Each Wrong Option is Incorrect**
**Option A:** *Nitroprusside* (a venodilator and arterial dilator) reduces afterload by decreasing preload and systemic vascular resistance.
**Option B:** *Enalapril* (an ACE inhibitor) lowers afterload by inhibiting angiotensin II synthesis, reducing vasoconstriction.
**Option D:** *Nifedipine* (a calcium channel blocker) dil